Expertise in
4
conditions

Dr. Lily C. Chao

Pediatric Endocrinology
Children's Hospital Los Angeles
550 S Beretania St Ste 201, 
Honolulu, HI 
Accepting New Patients
Referral may be required
Before you request
Expertise in
4
conditions
Children's Hospital Los Angeles
550 S Beretania St Ste 201, 
Honolulu, HI 

Overview

Lily Chao is a Pediatric Endocrinologist practicing medicine in Honolulu, Hawaii.

Dr. Chao is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Diabetic Ketoacidosis, Type 2 Diabetes (T2D), Maturity Onset Diabetes of the Young, and Type 1 Diabetes (T1D).

She is actively involved in clinical research, co-authoring 38 peer reviewed articles and participating in 2 clinical trials. Dr. Chao is currently accepting new patients.

Specialties

Pediatric Endocrinology

Licenses

Pediatric Endocrinology in CA

Hospital Affiliations

Children's Hosp Of Los Angeles

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Kaiser Permanente
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER MEDICARE
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 7 Less Insurance Carriers -

Locations

Children's Hospital Los Angeles
550 S Beretania St Ste 201, Honolulu, HI 96813

Additional Areas of Focus

Dr. Chao has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Non-Alcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis (NASH)
Pediatric Growth Hormone Deficiency

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study With an Open-Label Extension Assessing the Efficacy, Safety, and Pharmacokinetics/Pharmacodynamics of Tirzepatide in Pediatric and Adolescent Participants With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin, or Basal Insulin, or Both
Enrollment Status: Completed
Publish Date: September 26, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 3
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
A Randomized, Double-Blind Study With an Open-Label Extension Comparing the Effect of Once-Weekly Dulaglutide With Placebo in Pediatric Patients With Type 2 Diabetes Mellitus (AWARD-PEDS: Assessment of Weekly AdministRation of LY2189265 in Diabetes-PEDiatric Study)
Enrollment Status: Completed
Publish Date: July 01, 2022
Intervention Type: Drug
Study Drug: Dulaglutide
Study Phase: Phase 3
View 1 Less Clinical Trial

38 Total Publications

Response to comment on "Exploratory real-world experience with GLP-1 receptor agonists vs. metformin in youth with new-onset type 2 diabetes: a single-center retrospective study".
Response to comment on "Exploratory real-world experience with GLP-1 receptor agonists vs. metformin in youth with new-onset type 2 diabetes: a single-center retrospective study".
Journal: Journal of pediatric endocrinology & metabolism : JPEM
Published: March 18, 2026
Similar Doctors
Expertise in
7
conditions
Dr. Alaina P. Vidmar
Pediatric Endocrinology
Expertise in
7
conditions
Dr. Alaina P. Vidmar
Pediatric Endocrinology
Referral may be required
Before you request

Children's Hospital Los Angeles

550 S Beretania St Ste 201, 
Honolulu, HI 
 (0.1 miles away)
323-660-2450
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Alaina Vidmar is a Pediatric Endocrinologist practicing medicine in Honolulu, Hawaii. Dr. Vidmar is highly rated in 7 conditions, according to our data. Her clinical expertise encompasses Obesity, Obesity in Children, Diabetic Ketoacidosis, Congenital Adrenal Hyperplasia (CAH), and Sleeve Gastrectomy. Dr. Vidmar is currently accepting new patients.

Expertise in
2
conditions
Dr. Mimi Y. Kim
Pediatric Endocrinology
Expertise in
2
conditions
Dr. Mimi Y. Kim
Pediatric Endocrinology
Referral may be required
Before you request

Children's Hospital Los Angeles

550 S Beretania St Ste 201, 
Honolulu, HI 
 (0.1 miles away)
323-660-2450
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mimi Kim is a Pediatric Endocrinologist practicing medicine in Honolulu, Hawaii. Dr. Kim is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Congenital Adrenal Hyperplasia (CAH), Adrenal Insufficiency Pediatric, Menopause, Osteotomy, and Myringotomy. Dr. Kim is currently accepting new patients.

Expertise in
3
conditions
Dr. Ahlee T. Kim
Pediatric Endocrinology
Expertise in
3
conditions
Dr. Ahlee T. Kim
Pediatric Endocrinology
Referral may be required
Before you request

Children's Hospital Los Angeles

550 S Beretania St Ste 201, 
Honolulu, HI 
 (0.1 miles away)
323-660-2450
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Ahlee Kim is a Pediatric Endocrinologist practicing medicine in Honolulu, Hawaii. Dr. Kim is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Obesity in Children, Idiopathic Short Stature (ISS), Familial Short Stature (FSS), Short Stature (Growth Disorders), and Sleeve Gastrectomy. Dr. Kim is currently accepting new patients.

Frequently Asked Questions about Dr. Lily C. Chao

How do I make an appointment with Dr. Lily C. Chao?

You can book an appointment with Dr. Lily C. Chao by calling their office at 323-660-2450. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Lily C. Chao a top-rated expert for Diabetic Ketoacidosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Lily C. Chao is classified as an Advanced expert for Diabetic Ketoacidosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Lily C. Chao specialize in?

While Dr. Lily C. Chao is a Pediatric Endocrinology, they have specific expertise in Diabetic Ketoacidosis, Type 2 Diabetes (T2D), and Maturity Onset Diabetes of the Young. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Endocrinology.

Does Dr. Lily C. Chao participate in research or clinical trials?

Yes. Dr. Lily C. Chao has published 38 articles and abstracts on conditions like Diabetic Ketoacidosis. You can view a list of Dr. Lily C. Chao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Lily C. Chao accept my insurance?

Dr. Lily C. Chao accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 323-660-2450 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Chao's expertise for a condition
ConditionClose
      View All 17 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile